Peer-reviewed peptide guides written for sophisticated readers. No supplement-blog hand-waving. Every claim cited.
DSIP, Epitalon, Selank, the GH stack — what works at the architecture level.
Semaglutide, tirzepatide, retatrutide, AOD-9604 — the metabolic-hormone era.
MOTS-c, NAD+, Semax — mitochondrial bioenergetics and cognitive activation.
BPC-157, TB-500, KPV — soft tissue, gut, and tendon repair, honestly assessed.
Semax, Selank, Cerebrolysin — nootropics with peer-reviewed signal.
Epitalon, Sermorelin, NAD+ — what telomeres, GH pulse, and pineal restoration actually do.
GHK-Cu, BPC-157 — the copper peptide story, beyond the marketing.
IGF-1 LR3, MGF, CJC-1295/Ipamorelin — anabolic peptides in honest perspective.
PT-141, Melanotan II — melanocortin pathway in plain English.
Thymosin Alpha-1, LL-37, KPV — modulators, not boosters.
GHK-Cu, the topical/systemic protocol landscape.
BPC-157, TB-500, AOD-9604 — cartilage, synovium, and the regen window.
The most-studied recovery peptide. What the preclinical data shows and doesn't.
Principles, routes, reconstitution, cycling, monitoring — the unified framework.
Combinations that work, combinations to avoid, timing logic that matters.
Every article on the Research Hub goes through a four-step process: primary literature review, draft, clinical-advisor review, citation audit. We cite PubMed where applicable, distinguish preclinical from human trials, and we are explicit when the evidence is weak. Our standards are documented at Trust & Safety.
If you're new, start with the dosing guide and then read the pillar article for whatever ailment you're working on.